Erlotinib or gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: a systematic review
Article
Murphy, M. and Stordal, B. 2011. Erlotinib or gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: a systematic review. Drug Resistance Updates. 14 (3), pp. 177-190. https://doi.org/10.1016/j.drup.2011.02.004
Type | Article |
---|---|
Title | Erlotinib or gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: a systematic review |
Authors | Murphy, M. and Stordal, B. |
Abstract | BACKGROUND: |
Keywords | Platinum; Cisplatin; Erlotinib; Gefitinib; NSCLC; Ovarian cancer |
Research Group | Biomarkers for Cancer group |
Publisher | Elsevier |
Journal | Drug Resistance Updates |
ISSN | 1368-7646 |
Electronic | 1532-2084 |
Publication dates | |
Jun 2011 | |
Online | 24 Mar 2011 |
Publication process dates | |
Deposited | 17 Mar 2015 |
Accepted | 14 Feb 2011 |
Output status | Published |
Accepted author manuscript | |
Copyright Statement | © 2011. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/ |
Digital Object Identifier (DOI) | https://doi.org/10.1016/j.drup.2011.02.004 |
PubMed ID | 21435938 |
Web of Science identifier | WOS:000292623200004 |
Language | English |
https://repository.mdx.ac.uk/item/84z9z
Download files
63
total views12
total downloads1
views this month0
downloads this month